QUALITY BY DESIGN- A NEW APPROACH TO DRUG DEVELOPMENT

  • Rumel Dey
  • D.R. Chowdhury
DOI https://doi.org/10.22270/ijdra.v3i2.163

Abstract

Quality by design is an essential part of the modern approach to pharmaceutical quality. A new approach to drug development could increase efficiencies, provide regulatory relief and flexibility, and offer important business benefits throughout the product’s life cycle. QbD has become the answer to assist both industry and FDA to move towards a more scientific, risk based, holistic and proactive approach to pharmaceutical development.

Keywords: Food and Drug Administration (FDA), Quality by Design (QbD).

Downloads

Download data is not yet available.

References

1. DPT Thought Leadership. Issue 11: 1st in a series.
2. Shajeeya Amren. SK, Viswanath. A, Srinivasa Babu. P. Quality by Design- Novelty in Pharmaceuticals. World Journal of Pharmaceuticals research. 2013; 2(5):1409-22
3. John G. Lanese. “OOS: The Last Resort”, Pharmaceutical Formulation and Quality, 2011.
4. Agnes Shanley. “From the Editor: The cost of poor quality, Too high a price?”. Pharmaceutical Manufacturing; 2012.
5. Bill Schmidt. “Implementing Quality by Design: Are you ready or not?”www.pharmaqbd.com; 2010.
6. ICH Q8 (R1). Pharmaceutical Development: Quality by Design; 2006.
7. FDA CDER Draft guidance for industry and review staff. Target profile- Strategic development process tool; 2007.
8. ICH Q9- Quality Risk Management, step 4. [Internet]. ICH; 2005 [cited 2015 May 11]. Available from:
http://www.ich.org/cache/compo/276-254-1.htm
Statistics
714 Views | 1037 Downloads
How to Cite
1.
Dey R, Chowdhury D. QUALITY BY DESIGN- A NEW APPROACH TO DRUG DEVELOPMENT. Int J Drug Reg Affairs [Internet]. 2018Feb.13 [cited 2025Mar.20];3(2):8-16. Available from: https://www.ijdra.com/index.php/journal/article/view/163
Issue
Vol 3 No 2 (2015): VOLUME 3, ISSUE 2, 2015
Section
Review
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.

I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.

Download link for COPYRIGHT FORM